Drug-involved overdose deaths increased by over 500 percent in 2022 according to a study at Columbia University Mailman School of Public Health, with trends attributed to synthetic opioids.
Columbia University's Mailman School of Public Health Aug 5 2024 National data shows that fentanyl and heroin in particular attributed substantially to the rise particularly since 2014. However, the study also reports that income protection policies, can have a supportive role in preventing fatal drug overdoses. The findings are reported in the International Journal of Drug Policy.
"In the context of financial and economic stressors which are known to increase overdose risk we hypothesized that we would observe lower levels of overall overdose and opioid deaths given that robust unemployment insurance benefits could be a buffer," said Martins., who is also director of the Substance Use Epidemiology Unit of the Department of Epidemiology at Columbia.
"We also theorized that states and counties with limited safety net policies may increase an individual's social, psychological, and biological vulnerability to develop a drug use disorder, including opioid and stimulant use disorders. Such policies likely play a significant role in substance use initiation and subsequent development of substance use disorders as well as treatment access for such disorders," Martins noted.
"While their earlier analysis shows that, between 1999 to 2012, UI was associated with lower rates of opioid overdoses, our study builds and expands on findings from that research, as we examined the relationship between UI and any drug-involved mortality -- including all other drug overdoses and stimulant overdoses -- during the 4th wave of the epidemic intertwined with the COVID-19 period," observed Martins.
Education Epidemiology Fentanyl Heroin Mortality Opioids Overdose Pandemic Public Health Research
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Study finds that despite wanting to quit, only 8.8 percent quit smoking in 2022Although about two-thirds of U.S. adults who smoked wanted to quit, only 8.8 percent of smokers quit in 2022, according to research published in the July 25 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Weiterlesen »
Study reveals underuse of a key drug in patients with treatment-resistant schizophreniaThe Psychiatry and Mental Health research group at the Germans Trias i Pujol Research Institute (IGTP), together with the ETEP (Study and Treatment of Psychotic Episodes) group at Hospital del Mar, has published a study in the Spanish Journal of Psychiatry and Mental Health that analyzes the use of clozapine in patients with treatment-resistant...
Weiterlesen »
Study reveals how an anesthesia drug induces unconsciousnessThere are many drugs that anesthesiologists can use to induce unconsciousness in patients. Exactly how these drugs cause the brain to lose consciousness has been a longstanding question, but MIT neuroscientists have now answered that question for one commonly used anesthesia drug.
Weiterlesen »
Tell-tale gene affects success of drug used to treat chronic pain, study findsWomen who carry a particular form of a pain gene are more likely to respond well to a common medication used to treat long-term discomfort, research shows.
Weiterlesen »
Unlocking the mystery of preexisting drug resistance: Study sheds light on cancer evolutionThe evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge.
Weiterlesen »
Combination treatment based shows promise for treatment of retinal degenerations, drug repurposing study findsDrug repurposing shows promise in the treatment of retinal degenerations, according to a new study by an international team of researchers, published in Nature Communications. A combination treatment incorporating three existing drugs—tamsulosin, metoprolol and bromocriptine—slowed disease progression in pre-clinical retinopathy models.
Weiterlesen »